Hii C S, Stacey K, Moghaddami N, Murray A W, Ferrante A
Department of Immunopathology, Women's and Children's Hospital, North Adelaide, South Australia, Australia.
Infect Immun. 1999 Mar;67(3):1297-302. doi: 10.1128/IAI.67.3.1297-1302.1999.
Killing of Staphylococcus aureus and Candida albicans by neutrophils involves adherence of the microorganisms, phagocytosis, and a collaborative action of oxygen reactive species and components of the granules. While a number of intracellular signalling pathways have been proposed to regulate neutrophil responses, the extent to which each pathway contributes to the killing of S. aureus and C. albicans has not been clearly defined. We have therefore examined the effect of blocking one such pathway, the extracellular signal-regulated protein kinase (ERK) cascade, using the specific inhibitor of the mitogen-activated protein kinase/ERK kinase, PD98059, on the ability of human neutrophils to kill S. aureus and C. albicans. Our data demonstrate the presence of ERK2 and a 43-kDa form of ERK but not ERK1 in human neutrophils. Upon stimulation with formyl methionyl leucyl phenylalanine (fMLP), the activities of both ERK2 and the 43-kDa form were stimulated. Despite abrogating the activity of both ERK forms, PD98059 only slightly reduced the ability of neutrophils to kill S. aureus or C. albicans. This is consistent with our finding that PD98059 had no effect on neutrophil adherence or degranulation, although pretreatment of neutrophils with PD98059 inhibited fMLP-stimulated superoxide production by 50%, suggesting that a change in superoxide production per se is not strictly correlated with microbicidal activity. However, fMLP-stimulated chemokinesis was markedly inhibited, while random migration and fMLP-stimulated chemotaxis were partially inhibited, by PD98059. These data demonstrate, for the first time, that the ERK cascade plays only a minor role in the microbicidal activity of neutrophils and that the ERK cascade is involved primarily in regulating neutrophil migration in response to fMLP.
中性粒细胞对金黄色葡萄球菌和白色念珠菌的杀伤作用涉及微生物的黏附、吞噬作用,以及氧活性物质和颗粒成分的协同作用。虽然已经提出了许多细胞内信号通路来调节中性粒细胞的反应,但每条通路对金黄色葡萄球菌和白色念珠菌杀伤作用的贡献程度尚未明确界定。因此,我们使用丝裂原活化蛋白激酶/细胞外信号调节蛋白激酶激酶的特异性抑制剂PD98059,研究了阻断其中一条这样的通路——细胞外信号调节蛋白激酶(ERK)级联反应,对人中性粒细胞杀伤金黄色葡萄球菌和白色念珠菌能力的影响。我们的数据表明,人中性粒细胞中存在ERK2和一种43 kDa形式的ERK,但不存在ERK1。在用甲酰甲硫氨酰亮氨酰苯丙氨酸(fMLP)刺激后,ERK2和43 kDa形式的活性均受到刺激。尽管PD98059消除了两种ERK形式的活性,但它仅略微降低了中性粒细胞杀伤金黄色葡萄球菌或白色念珠菌的能力。这与我们的发现一致,即PD98059对中性粒细胞的黏附或脱颗粒没有影响,尽管用PD98059预处理中性粒细胞可使fMLP刺激的超氧化物产生抑制50%,这表明超氧化物产生的变化本身与杀菌活性并不严格相关。然而,PD98059显著抑制了fMLP刺激的化学运动,同时部分抑制了随机迁移和fMLP刺激的趋化性。这些数据首次表明,ERK级联反应在中性粒细胞杀菌活性中仅起次要作用,并且ERK级联反应主要参与调节中性粒细胞对fMLP的迁移反应。